| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $757.9M | -6.2% |
| R&D Expense | $77.3M | +14.3% |
| SG&A Expense | $4.0M | +0.0% |
| Operating Income | $89.2M | -50.3% |
| Pre-tax Income | $15.9M | -84.4% |
| Income Tax | $881K | -95.0% |
| Net Income | $15.0M | -82.1% |
| EPS (Basic) | $0.18 | -81.3% |
| EPS (Diluted) | $0.17 | -81.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $400.7M | +49.9% |
| Accounts Receivable | $87.9M | -18.6% |
| Inventory | $67.8M | -4.0% |
| Current Assets | $734.1M | -21.2% |
| Total Assets | $1.92B | -9.5% |
| Current Liabilities | $681.5M | -22.9% |
| Long-term Debt | $950.9M | -2.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $318.4M | +9.0% |
| Investing Cash Flow | -$156.2M | +23.6% |
| Financing Cash Flow | -$23.7M | +78.7% |
| Total Liabilities |
| $1.67B |
| -12.2% |
| Stockholders' Equity | $255.9M | +13.2% |